About Kevin Rosenblatt
Form D filings for Healix Clinical Laboratory in 2023 list Kevin Rosenblatt as executive officer and director.
Kevin Rosenblatt first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Rosenblatt in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Rosenblatt works with at each company, as listed on that company's latest Form D.
Healix Clinical Laboratory LLC · Form D, Jul 5, 2023
EH
Elenora Huber
Director
MM
Marc Mintz
Director
MN
Michael Niccolini
Director
PG
Peter Bryant-Greenwood
Chief Executive Officer and director
SS
Shea Spruill
Executive officer and director